secwatch.observer — SEC 8-K summary
======================================

Issuer:     OPKO HEALTH, INC. (OPK)
CIK:        0000944809
Form:       8-K
Filed at:   2026-06-18T20:06:31+00:00
Accession:  0001193125-26-275818
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

OPKO Health stockholders elect all 11 director nominees and approve 2026 equity plan at annual meeting
--------------------------------------------------------------------------------

- All 11 director nominees elected; Phillip Frost received 423.7M for, 40.2M against, 296K abstain.
- 2026 Equity Incentive Plan approved with 440.1M for, 23.7M against, 348K abstain.
- Non-binding advisory vote on executive compensation passed: 446.2M for, 17.5M against.
- Ratification of Ernst & Young as auditor for FY 2026 approved: 535.1M for, 6.1M against.
- No other matters were considered or voted upon at the June 18, 2026 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/944809/000119312526275818/0001193125-26-275818-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/944809/000119312526275818/opk-20260618.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-275818

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer